(3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one

C21H25NO4 — CID 11515922

IUPAC(3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one
SMILESC=C=C(c1ccccc1)[C@]1(OC)C(=O)N(CC=C)[C@H]1[C@H]1COC(C)(C)O1
InChIInChI=1S/C21H25NO4/c1-6-13-22-18(17-14-25-20(3,4)26-17)21(24-5,19(22)23)16(7-2)15-11-9-8-10-12-15/h6,8-12,17-18H,1-2,13-14H2,3-5H3/t17-,18+,21-/m1/s1
InChIKeyQYEFNGQHVQFZDJ-LVCYWYKZSA-N
MW355.43 g/mol
LogP2.79
Rot. Bonds6

About (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one

(3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one (PubChem CID 11515922) has the molecular formula C21H25NO4 and a molecular weight of 355.43 g/mol. Its IUPAC name is (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one.

Molecular Properties

Compound Name(3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one
PubChem CID11515922
Molecular FormulaC21H25NO4
Molecular Weight355.43 g/mol
Exact Mass355.18
IUPAC Name(3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one
SMILESC=C=C(c1ccccc1)[C@]1(OC)C(=O)N(CC=C)[C@H]1[C@H]1COC(C)(C)O1
InChIInChI=1S/C21H25NO4/c1-6-13-22-18(17-14-25-20(3,4)26-17)21(24-5,19(22)23)16(7-2)15-11-9-8-10-12-15/h6,8-12,17-18H,1-2,13-14H2,3-5H3/t17-,18+,21-/m1/s1
InChIKeyQYEFNGQHVQFZDJ-LVCYWYKZSA-N
XLogP2.79
TPSA48.00 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500355.43
LogP ≤ 52.79
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one?
The IUPAC name of (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one (CID 11515922) is (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one.
What is the SMILES notation for (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one?
The canonical SMILES for (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one is C=C=C(c1ccccc1)[C@]1(OC)C(=O)N(CC=C)[C@H]1[C@H]1COC(C)(C)O1.
What is the InChIKey of (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one?
The InChIKey is QYEFNGQHVQFZDJ-LVCYWYKZSA-N. The full InChI is InChI=1S/C21H25NO4/c1-6-13-22-18(17-14-25-20(3,4)26-17)21(24-5,19(22)23)16(7-2)15-11-9-8-10-12-15/h6,8-12,17-18H,1-2,13-14H2,3-5H3/t17-,18+,21-/m1/s1.
What are the key properties of (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one?
(3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one has a molecular weight of 355.43 g/mol, XLogP of 2.79, 6 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (3R,4S)-4-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-methoxy-3-(1-phenylpropa-1,2-dienyl)-1-prop-2-enylazetidin-2-one is sourced from PubChem (CID 11515922), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).